Keywords
Lantibiotic
Anti-Bacterial Agents
Bioengineering
Anti-Tumor Activity
Immunomodulation
Anti-Inflammatory Agents
How to Cite
Abstract
Nisin is a typical representative of class I bacteriocins belonging to subtype A1 lantibiotics. This lantibiotic is produced by gram-positive bacteria of the genera Lactococcus, Streptococcus, Staphylococcus, and Blautia. Currently, at least twelve natural variants of nisin are known. They differ in some physicochemical properties and biological activity. Nisin is generally recognized as safe (GRAS) and has been used as a food additive for seven decades. The current review presents the data from scientific reports over the past decade supporting the value of this lantibiotic as a therapeutic agent. Most research works demonstrate a high inhibitory potential of nisin against antibiotic-resistant bacteria when using alone and in combination with antibiotics. A number of studies prove the ability of nisin to modulate the composition of oral and intestinal microbiomes, to inhibit the growth of both bacteria causing infectious processes and bacterial pathogens associated with cancer. Nisin has been shown to have its own antitumor potential and to be able to enhance the therapeutic effect of chemotherapeutic drugs. There is convincing evidence of its immunomodulatory and anti-inflammatory activity. The reasons limiting its widespread application in clinical practice can be successfully eliminated via modern bioengineering technologies that improve the functional characteristics and stability of nisin in various physiological conditions.
References
Rogers LA, Whittier EO. Limiting factors in the lactic fermentation. Journal of Bacteriology. 1928;16(4):211–229. Available from: https://doi.org/10.1128/jb.16.4.211-229.1928
Meade, Slattery, Garvey. Bacteriocins, potent antimicrobial peptides and the fight against multi drug resistant species: resistance is futile? Antibiotics. 2020;9(1):32. Available from: https://doi.org/10.3390/antibiotics9010032
Kaur S, Kaur S. Bacteriocins as potential anticancer agents. Frontiers in Pharmacology. 2015;6:272. Available from: https://doi.org/10.3389/fphar.2015.00272
Gharsallaoui A, Oulahal N, Joly C, Degraeve P. Nisin as a food preservative: Part 1: physicochemical properties, antimicrobial activity, and main uses. Critical Reviews in Food Science and Nutrition. 2015;56(8):1262–1274. Available from: https://doi.org/10.1080/10408398.2013.763765
Shin JM, Gwak JW, Kamarajan P, Fenno JC, Rickard AH, Kapila YL. Biomedical applications of nisin. Journal of Applied Microbiology. 2016;120(6):1449–1465. Available from: https://doi.org/10.1111/jam.13033
Popa EE, Miteluț AC, Râpă M, Popescu PA, Drăghici MC, Geicu-Cristea M, et al. Antimicrobial active packaging containing nisin for preservation of products of animal origin: an overview. Foods. 2022;11(23):3820. Available from: https://doi.org/10.3390/foods11233820
Karpiński T, Adamczak A. Anticancer activity of bacterial proteins and peptides. Pharmaceutics. 2018;10(2):54. Available from: https://doi.org/10.3390/pharmaceutics10020054
Soltani S, Hammami R, Cotter PD, Rebuffat S, Said LB, Gaudreau H, et al. Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations. FEMS Microbiology Reviews. 2020;45(1):fuaa039. Available from: https://doi.org/10.1093/femsre/fuaa039
Lewies A, Du Plessis LH, Wentzel JF. The cytotoxic, antimicrobial and anticancer properties of the antimicrobial peptide nisin Z alone and in combination with conventional treatments. In: Çelik TA, ed. Cytotoxicity, London: IntechOpen Limited; 2018. Available from: https://doi.org/10.5772/intechopen.71927
Cui H, Wu J, Li C, Lin L. Improving anti-listeria activity of cheese packaging via nanofiber containing nisin-loaded nanoparticles. LWT - Food Science and Technology. 2017;81:233–242. Available from: https://doi.org/10.1016/j.lwt.2017.04.003
Lewies A, Wentzel JF, Jordaan A, Bezuidenhout C, Du Plessis LH. Interactions of the antimicrobial peptide nisin Z with conventional antibiotics and the use of nanostructured lipid carriers to enhance antimicrobial activity. International Journal of Pharmaceutics. 2017;526(1–2):244–253. Available from: https://doi.org/10.1016/j.ijpharm.2017.04.071
Khan A, Vu KD, Riedl B, Lacroix M. Optimization of the antimicrobial activity of nisin, Na-EDTA and pH against gram-negative and gram-positive bacteria. LWT - Food Science and Technology. 2015;61(1):124–129. Available from: https://doi.org/10.1016/j.lwt.2014.11.035
Cotter PD, Ross RP, Hill C. Bacteriocins — a viable alternative to antibiotics? Nature Reviews Microbiology. 2012;11(2):95–105. Available from: https://doi.org/10.1038/nrmicro2937
Sivaraj A, Sundar R, Manikkam R, Parthasarathy K, Rani U, Kumar V. Potential applications of lactic acid bacteria and bacteriocins in anti-mycobacterial therapy. Asian Pacific Journal of Tropical Medicine. 2018;11(8):453. Available from: https://doi.org/10.4103/1995-7645.240080
Hols P, Ledesma-García L, Gabant P, Mignolet J. Mobilization of microbiota commensals and their bacteriocins for therapeutics. Trends in Microbiology. 2019;27(8):690–702. Available from: https://doi.org/10.1016/j.tim.2019.03.007
O’Connor PM, O’Shea EF, Guinane CM, O’Sullivan O, Cotter PD, Ross RP, et al. Nisin H is a new nisin variant produced by the gut-derived strain Streptococcus hyointestinalis DPC6484. Applied and Environmental Microbiology. 2015;81(12):3953–3960. Available from: https://doi.org/10.1128/AEM.00212-15
Lawrence GW, Garcia-Gutierrez E, Walsh CJ, O’Connor PM, Begley M, Cotter PD, et al. Nisin G is a novel nisin variant produced by a gut-derived Streptococcus salivarius [Internet]. bioRxiv [preprint]. 2022;480493. Available from: https://doi.org/10.1101/2022.02.15.480493
Hatziioanou D, Gherghisan-Filip C, Saalbach G, Horn N, Wegmann U, Duncan SH, et al. Discovery of a novel lantibiotic nisin O from Blautia obeum A2-162, isolated from the human gastrointestinal tract. Microbiology. 2017;163(9):1292–1305. Available from: https://doi.org/10.1099/mic.0.000515
O’Sullivan JN, O’Connor PM, Rea MC, O’Sullivan O, Walsh CJ, Healy B, et al. Nisin J, a Novel Natural Nisin Variant, Is Produced by Staphylococcus capitis Sourced from the Human Skin Microbiota. Journal of Bacteriology. 2020;202(3):e00639-19. Available from: https://doi.org/10.1128/JB.00639-19
Field D, Cotter PD, Ross RP, Hill C. Bioengineering of the model lantibiotic nisin. Bioengineered. 2015;6(4):187–192. Available from: https://doi.org/10.1080/21655979.2015.1049781
Abdollahi S, Ghahremani MH, Setayesh N, Samadi N. Listeria monocytogenes and Salmonella enterica affect the expression of nisin gene and its production by Lactococcus lactis. Microbial Pathogenesis. 2018;123:28–35. Available from: https://doi.org/10.1016/j.micpath.2018.06.024
Kitagawa N, Otani T, Inai T. Nisin, a food preservative produced by Lactococcus lactis, affects the localization pattern of intermediate filament protein in HaCaT cells. Anatomical Science International. 2018;94(2):163–171. Available from: https://doi.org/10.1007/s12565-018-0462-x
Shin JM, Ateia I, Paulus JR, Liu H, Fenno JC, Rickard AH, et al. Antimicrobial nisin acts against saliva derived multi-species biofilms without cytotoxicity to human oral cells. Frontiers in Microbiology. 2015;6:617. Available from: https://doi.org/10.3389/fmicb.2015.00617
Moein M, Imani Fooladi AA, Mahmoodzadeh Hosseini H. Determining the effects of green chemistry synthesized Ag-nisin nanoparticle on macrophage cells. Microbial Pathogenesis. 2018;114:414–419. Available from: https://doi.org/10.1016/j.micpath.2017.12.034
Gough R, Cabrera Rubio R, O’Connor PM, Crispie F, Brodkorb A, Miao S, et al. Oral delivery of nisin in resistant starch based matrices alters the gut microbiota in mice. Frontiers in Microbiology. 2018;9:1186. Available from: https://doi.org/10.3389/fmicb.2018.01186
Younes M, Aggett P, Aguilar F, Crebelli R, Dusemund B, Filipič M, et al. Safety of nisin (E 234) as a food additive in the light of new toxicological data and the proposed extension of use. EFSA Journal. 2017;15(12):e05063. Available from: https://doi.org/10.2903/j.efsa.2017.5063
Punyauppa-Path S, Phumkhachorn P, Rattanachaikunsopon P. Nisin: production and mechanism of antimicrobial action. International Journal of Current Research and Review. 2015;7(2):47–53.
Prince A, Sandhu P, Ror P, Dash E, Sharma S, Arakha M, et al. Lipid-II independent antimicrobial mechanism of nisin depends on its crowding and degree of oligomerization. Scientific Reports. 2016;6(1):37908. Available from: https://doi.org/10.1038/srep37908
Galván Márquez IJ, McKay B, Wong A, Cheetham JJ, Bean C, Golshani A, et al. Mode of action of nisin on Escherichia coli. Canadian Journal of Microbiology. 2020;66(2):161–168. Available from: https://doi.org/10.1139/cjm-2019-0315
Jensen C, Li H, Vestergaard M, Dalsgaard A, Frees D, Leisner JJ. Nisin damages the septal membrane and triggers DNA condensation in methicillin-resistant Staphylococcus aureus. Frontiers in Microbiology. 2020;11:1007. Available from: https://doi.org/10.3389/fmicb.2020.01007
Anumudu C, Hart A, Miri T, Onyeaka H. Recent advances in the application of the antimicrobial peptide nisin in the inactivation of spore-forming bacteria in foods. Molecules. 2021;26(18):5552. Available from: https://doi.org/10.3390/molecules26185552
Yehia HM, Alkhuriji AF, Savvaidis I, Al-Masoud AH. Bactericidal effect of nisin and reuterin on methicillin-resistant Staphylococcus aureus (MRSA) and S. aureus ATCC 25937. Food Science and Technology. 2022;42:e105321. Available from: https://doi.org/10.1590/fst.105321
Ghapanvari P, Taheri M, Jalilian FA, Dehbashi S, Dezfuli AAZ, Arabestani MR. The effect of nisin on the biofilm production, antimicrobial susceptibility and biofilm formation of Staphylococcus aureus and Pseudomonas aeruginosa. European Journal of Medical Research. 2022;27(1):173. Available from: https://doi.org/10.1186/s40001-022-00804-x
Field D, O’ Connor R, Cotter PD, Ross RP, Hill C. In vitro activities of nisin and nisin derivatives alone and in combination with antibiotics against Staphylococcus biofilms. Frontiers in Microbiology. 2016;7:508. Available from: https://doi.org/10.3389/fmicb.2016.00508
Roshanak S, Shahidi F, Yazdi FT, Javadmanesh A, Movaffagh J. Evaluation of antimicrobial activity of buforin I and nisin and the synergistic effect of their combination as a novel antimicrobial preservative. Journal of Food Protection. 2020;83(11):2018–2025. Available from: https://doi.org/10.4315/JFP-20-127
Ng ZJ, Zarin MA, Lee CK, Tan JS. Application of bacteriocins in food preservation and infectious disease treatment for humans and livestock: a review. RSC Advances. 2020;10(64):38937–38964. Available from: https://doi.org/10.1039/D0RA06161A
Li Q, Montalban-Lopez M, Kuipers OP. Increasing the antimicrobial activity of nisin-based lantibiotics against Gram-negative pathogens. Applied and Environmental Microbiology. 2018;84(12):e00052-18. Available from: https://doi.org/10.1128/AEM.00052-18
Zhou L, van Heel AJ, Montalban-Lopez M, Kuipers OP. Potentiating the activity of nisin against Escherichia coli. Frontiers in Cell and Developmental Biology. 2016;4:7. Available from: https://doi.org/10.3389/fcell.2016.00007
Özdemir FN, Buzrul S, Özdemir C, Akçelik N, Akçelik M. Determination of an effective agent combination using nisin against Salmonella biofilm. Archives of Microbiology. 2022;204(3):167. Available from: https://doi.org/10.1007/s00203-022-02766-4
Prudêncio CV, Mantovani HC, Cecon PR, Vanetti MCD. Differences in the antibacterial activity of nisin and bovicin HC5 against Salmonella
Typhimurium under different temperature and pH conditions. Journal of Applied Microbiology. 2014;118(1):18–26. Available from: https://doi.org/10.1111/jam.12680
Müller-Auffermann K, Grijalva F, Jacob F, Hutzler M. Nisin and its usage in breweries: a review and discussion. Journal of the Institute of Brewing. 2015;121(3):309–319. Available from: https://doi.org/10.1002/jib.233
Church NA, McKillip JL. Antibiotic resistance crisis: challenges and imperatives. Biologia. 2021;76(5):1535–1550. Available from: https://doi.org/10.1007/s11756-021-00697-x
Ghodhbane H, Elaidi S, Sabatier J-M, Achour S, Benhmida J, Regaya I. Bacteriocins active against multi-resistant Gram negative bacteria implicated in nosocomial infections. Infectious Disorders - Drug Targets. 2015;15(1):2–12. Available from: https://doi.org/10.2174/1871526514666140522113337
de Kraker MEA, Stewardson AJ, Harbarth S. Will 10 million people die a year due to antimicrobial resistance by 2050? PLOS Medicine. 2016;13(11):e1002184. Available from: https://doi.org/10.1371/journal.pmed.1002184
Jia Z, Chen A, Bao F, He M, Gao S, Xu J, et al. Effect of nisin on microbiome-brain-gut axis neurochemicals by Escherichia coli -induced diarrhea in mice. Microbial Pathogenesis. 2018;119:65–71. Available from: https://doi.org/10.1016/j.micpath.2018.04.005
Lewies A, Du Plessis LH, Wentzel JF. Antimicrobial peptides: the Achilles’ heel of antibiotic resistance? Probiotics and Antimicrobial Proteins. 2018;11(2):370–381. Available from: https://doi.org/10.1007/s12602-018-9465-0
Enigk K, Jentsch H, Rodloff AC, Eschrich K, Stingu C-S. Activity of five antimicrobial peptides against periodontal as well as non-periodontal pathogenic strains. Journal of Oral Microbiology. 2020;12(1):1829405. Available from: https://doi.org/10.1080/20002297.2020.1829405
Mataraci E, Dosler S. In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms. Antimicrobial Agents and Chemotherapy. 2012;56(12):6366–6371. Available from: https://doi.org/10.1128/AAC.01180-12
Geitani R, Ayoub Moubareck C, Touqui L, Karam Sarkis D. Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa. BMC Microbiology. 2019;19(1):54. Available from: https://doi.org/10.1186/s12866-019-1416-8
Le MN-T, Kawada-Matsuo M, Komatsuzawa H. Efficiency of antimicrobial peptides against multidrug-resistant Staphylococcal pathogens. Frontiers in Microbiology. 2022;13:930629. Available from: https://doi.org/10.3389/fmicb.2022.930629
Ellis J-C, Ross RP, Hill C. Nisin Z and lacticin 3147 improve efficacy of antibiotics against clinically significant bacteria. Future Microbiology. 2019;14(18):1573–1587. Available from: https://doi.org/10.2217/fmb-2019-0153
Dosler S, Gerceker AA. In vitro activities of antimicrobial cationic peptides; melittin and nisin, alone or in combination with antibiotics against Gram-positive bacteria. Journal of Chemotherapy. 2012;24(3):137–143. Available from: https://doi.org/10.1179/1973947812Y.0000000007
Tong Z, Zhang Y, Ling J, Ma J, Huang L, Zhang L. An in vitro study on the effects of nisin on the antibacterial activities of 18 antibiotics against Enterococcus faecalis. PLoS ONE. 2014;9(2):e89209. Available from: https://doi.org/10.1371/journal.pone.0089209
Naghmouchi K, Le Lay C, Baah J, Drider D. Antibiotic and antimicrobial peptide combinations: synergistic inhibition of Pseudomonas fluorescens and antibiotic-resistant variants. Research in Microbiology. 2012;163(2):101–108. Available from: https://doi.org/10.1016/j.resmic.2011.11.002
Singh AP, Preet S, Rishi P. Nisin/β-lactam adjunct therapy against Salmonella enterica serovar Typhimurium: a mechanistic approach. Journal of Antimicrobial Chemotherapy. 2014;69(7):1877–1887. Available from: https://doi.org/10.1093/jac/dku049
Liu J, Huang R, Song Q, Xiong H, Ma J, Xia R, et al. Combinational Antibacterial Activity of Nisin and 3-Phenyllactic Acid and Their Co-production by Engineered Lactococcus lactis. Frontiers in Bioengineering and Biotechnology. 2021;9:612105. Available from: https://doi.org/10.3389/fbioe.2021.612105
Ahire JJ, Dicks LMT. Nisin incorporated with 2,3-dihydroxybenzoic acid in nanofibers inhibits biofilm formation by a methicillin-resistant strain of Staphylococcus aureus. Probiotics and Antimicrobial Proteins. 2014;7(1):52–59. Available from: https://doi.org/10.1007/s12602-014-9171-5
Wang H, Niu Y, Pan J, Li Q, Lu R. Antibacterial effects of Lactobacillus acidophilus surface-layer protein in combination with nisin against Staphylococcus aureus. LWT. 2020;124:109208. Available from: https://doi.org/10.1016/j.lwt.2020.109208
Klangpetch W, Noma S. Inhibitory effects of nisin combined with plant-derived antimicrobials on pathogenic bacteria and the interaction with complex food systems. Food Science and Technology Research. 2018;24(4):609–617. Available from: https://doi.org/10.3136/fstr.24.609
Shi C, Zhang X, Zhao X, Meng R, Liu Z, Chen X, et al. Synergistic interactions of nisin in combination with cinnamaldehyde against Staphylococcus aureus in pasteurized milk. Food Control. 2017;71:10–16. Available from: https://doi.org/10.1016/j.foodcont.2016.06.020
Slootweg JC, Liskamp RMJ, Rijkers DTS. Scalable purification of the lantibiotic nisin and isolation of chemical/enzymatic cleavage fragments suitable for semi-synthesis. Journal of Peptide Science. 2013;19(11):692–699. Available from: https://doi.org/10.1002/psc.2551
Zheng Y, Du Y, Qiu Z, Liu Z, Qiao J, Li Y, et al. Nisin variants generated by protein engineering and their properties. Bioengineering. 2022;9(6):251. Available from: https://doi.org/10.3390/bioengineering9060251
Rouse S, Field D, Daly KM, O’Connor PM, Cotter PD, Hill C, et al. Bioengineered nisin derivatives with enhanced activity in complex matrices. Microbial Biotechnology. 2012;5(4):501–508. Available from: https://doi.org/10.1111/j.1751-7915.2011.00324.x
Yang S-C, Lin C-H, Sung CT, Fang J-Y. Antibacterial activities of bacteriocins: application in foods and pharmaceuticals. Frontiers in Microbiology. 2014;5:241. Available from: https://doi.org/10.3389/fmicb.2014.00241
Molloy EM, Field D, Connor PMO, Cotter PD, Hill C, Ross RP. Saturation mutagenesis of lysine 12 leads to the identification of derivatives of nisin A with enhanced antimicrobial activity. PLoS ONE. 2013;8(3):e58530. Available from: https://doi.org/10.1371/journal.pone.0058530
Healy B, Field D, O’Connor PM, Hill C, Cotter PD, Ross RP. Intensive Mutagenesis of the Nisin Hinge Leads to the Rational Design of Enhanced Derivatives. PPLoS ONE. 2013;8(11):e79563. Available from: https://doi.org/10.1371/journal.pone.0079563
Zhou L, van Heel AJ, Kuipers OP. The length of a lantibiotic hinge region has profound influence on antimicrobial activity and host specificity. Frontiers in Microbiology. 2015;6:11. Available from: https://doi.org/10.3389/fmicb.2015.00011
Field D, Begley M, O’Connor PM, Daly KM, Hugenholtz F, Cotter PD, et al. Bioengineered nisin A derivatives with enhanced activity against both Gram positive and Gram negative pathogens. PLoS ONE. 2012;7(10):e46884. Available from: https://doi.org/10.1371/journal.pone.0046884
Mitchell SA, Truscott F, Dickman R, Ward J, Tabor AB. Simplified lipid II-binding antimicrobial peptides: Design, synthesis and antimicrobial activity of bioconjugates of nisin rings A and B with pore-forming peptides. Bioorganic & Medicinal Chemistry. 2018;26(21):5691–5700. Available from: https://doi.org/10.1016/j.bmc.2018.10.015
Zhao X, Yin Z, Breukink E, Moll GN, Kuipers OP. An engineered double lipid II binding motifs-containing lantibiotic displays potent and selective antimicrobial activity against Enterococcus faecium. Antimicrobial Agents and Chemotherapy. 2020;64(6):e02050-19. Available from: https://doi.org/10.1128/AAC.02050-19
Zhao X, Kuipers OP. Nisin- and ripcin-derived hybrid lanthipeptides display selective antimicrobial activity against Staphylococcus aureus. ACS Synthetic Biology. 2021;10(7):1703–1714. Available from: https://doi.org/10.1021/acssynbio.1c00080
Kong W, Lu T. Cloning and Optimization of a Nisin Biosynthesis Pathway for Bacteriocin Harvest. ACS Synthetic Biology. 2014;3(7):439–445. Available from: https://doi.org/10.1021/sb500225r
Wu L, Li F, Ran L, Gao Y, Xie P, Yang J, et al. Insight into the effects of nisin and cecropin on the oral microbial community of rats by high-throughput sequencing. Frontiers in Microbiology. 2020;11:1082. Available from: https://doi.org/10.3389/fmicb.2020.01082
Tong Z, Ni L, Ling J. Antibacterial peptide nisin: a potential role in the inhibition of oral pathogenic bacteria. Peptides. 2014;60:32–40. Available from: https://doi.org/10.1016/j.peptides.2014.07.020
Gao L, Kuraji R, Zhang MJ, Martinez A, Radaic A, Kamarajan P, et al. Nisin probiotic prevents inflammatory bone loss while promoting reparative proliferation and a healthy microbiome. npj Biofilms and Microbiomes. 2022;8(1):45. Available from: https://doi.org/10.1038/s41522-022-00307-x
Kapila Y, Gao L, Kuraji R, Zhang MJ, Martinez A, Kamarajan P, et al. Nisin probiotic prevents periodontal disease and inflammation while promoting periodontal regeneration and a shift toward a healthy microbiome/virome [Internet]. Research Square [preprint]. 2021. Available from: https://doi.org/10.21203/rs.3.rs-599805/v1
Radaic A, Brody H, Contreras F, Hajfathalian M, Lucido L, Kamarajan P, et al. Nisin and nisin probiotic disrupt oral pathogenic biofilms and restore their microbiome composition towards healthy control levels in a peri-implantitis setting. Microorganisms. 2022;10(7):1336. Available from: https://doi.org/10.3390/microorganisms10071336
Lay CL, Dridi L, Bergeron MG, Ouellette M, Fliss I. Nisin is an effective inhibitor of Clostridium difficile vegetative cells and spore germination. Journal of Medical Microbiology. 2016;65(2):169–175. Available from: https://doi.org/10.1099/jmm.0.000202
Hassan H, Gomaa A, Subirade M, Kheadr E, St-Gelais D, Fliss I. Novel design for alginate/resistant starch microcapsules controlling nisin release. International Journal of Biological Macromolecules. 2020;153:1186–1192. Available from: https://doi.org/10.1016/j.ijbiomac.2019.10.248
Khazaei Monfared Y, Mahmoudian M, Cecone C, Caldera F, Zakeri-Milani P, Matencio A, et al. Stabilization and anticancer enhancing activity of the peptide nisin by cyclodextrin-based nanosponges against colon and breast cancer cells. Polymers. 2022;14(3):594. Available from: https://doi.org/10.3390/polym14030594
Dicks LMT, Dreyer L, Smith C, van Staden AD. A review: the fate of bacteriocins in the human gastro-intestinal tract: do they cross the gut–blood barrier? Frontiers in Microbiology. 2018;9:2297. Available from: https://doi.org/10.3389/fmicb.2018.02297
O’Reilly C, O’Connor PM, O’Sullivan Ó, Rea MC, Hill C, Ross RP. Impact of nisin on Clostridioides difficile and microbiota composition in a faecal fermentation model of the human colon. Journal of Applied Microbiology. 2021;132(2):1397–1408. Available from: https://doi.org/10.1111/jam.15250
Baindara P, Korpole S, Grover V. Bacteriocins: perspective for the development of novel anticancer drugs. Applied Microbiology and Biotechnology. 2018;102(24):10393–1408. Available from: https://doi.org/10.1007/s00253-018-9420-8
Azmi MF, Al Khateeb A, Froemming GA, Ab Rahim S, Omar E. Nisin as a potential anticancer agent. Science, Engineering and Health Studies. 2021; 15:21010007. Available from: https://doi.org/10.14456/sehs.2021.30
Norouzi Z, Salimi A, Halabian R, Fahimi H. Nisin, a potent bacteriocin and anti-bacterial peptide, attenuates expression of metastatic genes in colorectal cancer cell lines. Microbial Pathogenesis. 2018;123:183–189. Available from: https://doi.org/10.1016/j.micpath.2018.07.006
Paiva AD, de Oliveira MD, de Paula SO, Baracat-Pereira MC, Breukink E, Mantovani HC. Toxicity of bovicin HC5 against mammalian cell lines and the role of cholesterol in bacteriocin activity. Microbiology. 2012;158(11):2851–2858. Available from: https://doi.org/10.1099/mic.0.062190-0
Ibrahim NE-S, Morsy H, Abdelgwad M. The comparative effect of nisin and thioridazine as potential anticancer agents on hepatocellular carcinoma. Reports of Biochemistry and Molecular Biology. 2021;9(4):452–462. Available from: https://doi.org/10.52547/rbmb.9.4.452
Joo NE, Ritchie K, Kamarajan P, Miao D, Kapila YL. Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1. Cancer Medicine. 2012;1(3):295–305. Available from: https://doi.org/10.1002/cam4.35
Kamarajan P, Hayami T, Matte B, Liu Y, Danciu T, Ramamoorthy A, et al. Nisin ZP, a bacteriocin and food preservative, inhibits head and neck cancer tumorigenesis and prolongs survival. PLOS ONE. 2015;10(7):e0131008. Available from: https://doi.org/10.1371/journal.pone.0131008
Ahmadi S, Ghollasi M, Hosseini HM. The apoptotic impact of nisin as a potent bacteriocin on the colon cancer cells. Microbial Pathogenesis. 2017;111:193–197. Available from: https://doi.org/10.1016/j.micpath.2017.08.037
Hosseini SS, Goudarzi H, Ghalavand Z, Hajikhani B, Rafeieiatani Z, Hakemi-Vala M. Anti-proliferative effects of cell wall, cytoplasmic extract of Lactococcus lactis and nisin through down-regulation of cyclin D1 on SW480 colorectal cancer cell line. Iranian Journal of Microbiology. 2020;12(5):424–430. Available from: https://doi.org/10.18502/ijm.v12i5.4603
Hosseini SS, Hajikhani B, Faghihloo E, Goudarzi H. Increased Expression of Caspase Genes in Colorectal Cancer Cell Line by Nisin. Archives of Clinical Infectious Diseases. 2020;15(2):e97734. Available from: https://doi.org/10.5812/archcid.97734
Lewies A, Wentzel JF, Miller HC, Du Plessis LH. The antimicrobial peptide nisin Z induces selective toxicity and apoptotic cell death in cultured melanoma cells. Biochimie. 2018;144:28–40. Available from: https://doi.org/10.1016/j.biochi.2017.10.009
Zainodini N, Hassanshahi G, Hajizadeh MR, Falahati-Pour S, Mahmoodi M, Mirzaei MR. Nisin induces cytotoxicity and apoptosis in human asterocytoma cell line (SW1088). Asian Pac J Cancer Prev. 2018;19(8):2217–2221. Available from: https://doi.org/10.22034/APJCP.2018.19.8.2217
Prince A, Tiwari A, Ror P, Sandhu P, Roy J, Jha S, et al. Attenuation of neuroblastoma cell growth by nisin is mediated by modulation of phase behavior and enhanced cell membrane fluidity. Physical Chemistry Chemical Physics. 2019;21(4):1980–1987. Available from: https://doi.org/10.1039/C8CP06378H
Mohammadi P, Zangeneh M, Mohammadi-Motlagh H-R, Khademi F, et al. The antimicrobial peptide, nisin, synergistically enhances the cytotoxic and apoptotic effects of rituximab treatment on human burkitt’s lymphoma cell lines. Reports of Biochemistry and Molecular Biology. 2020;9(3):250–256. Available from: https://doi.org/10.29252/rbmb.9.3.250
Sadri H, Aghaei M, Akbari V. Nisin induces apoptosis in cervical cancer cells via reactive oxygen species generation and mitochondrial membrane potential changes. Biochemistry and Cell Biology. 2022;100(2):136–141. Available from: https://doi.org/10.1139/bcb-2021-0225
Goudarzi F, Esmaeilzadeh M, Yaghoubi H. The mechanisms of anticancer activity of nisin peptide on myelogenous leukemia cell line (K562) as a new treatment: inducing apoptosis by changing in the expression of Bax and Bcl-2 genes. International Journal of Peptide Research and Therapeutics. 2021;27(4):2661–2670. Available from: https://doi.org/10.1007/s10989-021-10281-1
Preet S, Bharati S, Panjeta A, Tewari R, Rishi P. Effect of nisin and doxorubicin on DMBA-induced skin carcinogenesis — a possible adjunct therapy. Tumor Biology. 2015;36(11):8301–8308. Available from: https://doi.org/10.1007/s13277-015-3571-3
Rana K, Sharma R, Preet S. Augmented therapeutic efficacy of 5-fluorouracil in conjunction with lantibiotic nisin against skin cancer. Biochemical and Biophysical Research Communications. 2019;520(3):551–559. Available from: https://doi.org/10.1016/j.bbrc.2019.10.058
Małaczewska J, Kaczorek-Łukowska E. Nisin—A lantibiotic with immunomodulatory properties: a review. Peptides. 2021;137:170479. Available from: https://doi.org/10.1016/j.peptides.2020.170479
Hernández-González JC, Martínez-Tapia A, Lazcano-Hernández G, García-Pérez BE, Castrejón-Jiménez NS. Bacteriocins from lactic acid bacteria. A powerful alternative as antimicrobials, probiotics, and immunomodulators in veterinary medicine. Animals. 2021;11(4):979. Available from: https://doi.org/10.3390/ani11040979
Mouritzen MV, Andrea A, Qvist K, Poulsen SS, Jenssen H. Immunomodulatory potential of Nisin A with application in wound healing. Wound Repair and Regeneration. 2019;27(6):650–660. Available from: https://doi.org/10.1111/wrr.12743
Brand AM, Smith C, Dicks LMT. The effects of continuous in vivo administration of nisin on Staphylococcus aureus infection and immune response in mice. Probiotics and Antimicrobial Proteins. 2013;5(4):279–286. Available from: https://doi.org/10.1007/s12602-013-9141-3
Kindrachuk J, Jenssen H, Elliott M, Nijnik A, Magrangeas-Janot L, Pasupuleti M, et al. Manipulation of innate immunity by a bacterial secreted peptide: lantibiotic nisin Z is selectively immunomodulatory. Innate Immunity. 2012;19(3):315–327. Available from: https://doi.org/10.1177/1753425912461456
Małaczewska J, Kaczorek‐Łukowska E, Wójcik R, Rękawek W, Siwicki AK. In vitro immunomodulatory effect of nisin on porcine leucocytes. Journal of Animal Physiology and Animal Nutrition. 2019;103(3):882–893. Available from: https://doi.org/10.1111/jpn.13085
Jia Z, He M, Wang C, Chen A, Zhang X, Xu J, et al. Nisin reduces uterine inflammation in rats by modulating concentrations of pro‐ and anti‐inflammatory cytokines. American Journal of Reproductive Immunology. 2019;81(5):e13096. Available from: https://doi.org/10.1111/aji.13096
Huang F, Teng K, Liu Y, Wang T, Xia T, Yun F, et al. Nisin Z attenuates lipopolysaccharide-induced mastitis by inhibiting the ERK1/2 and p38 mitogen-activated protein kinase signaling pathways. Journal of Dairy Science. 2022;105(4):3530–3543. Available from: https://doi.org/10.3168/jds.2021-21356
Malvisi M, Stuknytė M, Magro G, Minozzi G, Giardini A, De Noni I, et al. Antibacterial activity and immunomodulatory effects on a bovine mammary epithelial cell line exerted by nisin A-producing Lactococcus lactis strains. Journal of Dairy Science. 2016;99(3):2288–2296. Available from: https://doi.org/10.3168/jds.2015-10161
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.